SearchOur managers will contact you as soon as possible.
Health care begins with prevention and healthy lifestyle. That is why “InterChem” has decided to expand the product range by adding a dietary supplement to contribute the maintenance and promotion of health.
Dietary supplement “Ginkgoba” – a drug of natural origin, which contains an extract of Ginkgo biloba leaves (Ginkgo biloba L., folium). Effect of the drug caused by unique phytochemical composition of plants, comprising flavonoid glycosides, which include kaempferol, kvartsetin, gingolid and terpenes – ginkgolides, bilobalide.
Ginkgo Biloba – the only plant, which comprises ginkgolides, capable of enhancing the elasticity of the vascular walls of the brain and dilate blood vessels. The result action of gingkolides is to improve oxygen supply to the brain, increasing mental alertness and operability, improve memory, concentration.
To useful action of Ginkgo Biloba also include the improvement of rheological properties of blood, increasing the resistance of tissues to hypoxia. Furthermore, plant active substances have a antioxidant activity, protect cells and tissues from damage by free radicals and peroxides, have a pronounced neuroprotective action.
Recent publications
InterChem CEO Anatoliy Reder joined the Ukrainian delegation on a business visit to Riyadh
The purpose of the trip was to strengthen economic cooperation between Ukraine and the Kingdom of Saudi Arabia and to present the capabilities ...
InterChem Among the Top 13 Best Educational Projects in Ukraine
InterChem has been recognized among the Top 13 Best Educational Projects initiated by Ukrainian businesses. Within the national project “Investing in Education”, the ...
InterChem at URC 2025: Signing of the Ukraine–EU Memorandum on Critical Medicines
Anatoliy Reder, CEO of InterChem and official representative of the Association of Ukrainian Medicines Manufacturers (AULM), signed a Memorandum of Cooperation between Ukraine ...
Anatoliy Reder, CEO of InterChem, ranked among Ukraine’s Top 50 CEOs
Anatoliy Reder became the winner in the nomination “Leader in Pharmaceutical Research and Innovation” in Ukraine’s national Top 50 CEOs ranking. The list ...